C-CHANGE
The Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) is a nationally endorsed guideline process that targets primary health care practitioners.
C-CHANGE is a composite of nine of Canada’s cardiovascular-focused clinical practice guidelines chosen to meet primary care needs, including managing patients with multiple co-morbidities. These guidelines have been part of Canada’s robust and successful cardiovascular guideline efforts since 2011.
LEARN MORE ABOUT C-CHANGE.
CHEP+
CHEP+ is the implementation and dissemination arm of
C-CHANGE.
The mission of CHEP+ is to improve health care quality and patient safety. This is done with enhanced professional development, and health consumer education.
OF INTEREST:
Hypertensive Disorder of
Pregnancy Research
Her-HEART is a program to educate women with a history of hypertensive disorder of pregnancy on their future cardiovascular risks. This link provides information for healthcare practitioners caring for women with a history of a hypertensive disorder, with recommendations on how to improve their long-term cardiovascular risk profile.
>> LEARN MORE
Upcoming online workshops
May 27, 2020
Management of Hypertension in Non-diabetes Patients with Chronic Kidney Disease
Speaker: Dr. Sheldon Tobe
Learn more and register:
htn-ckd-may27.eventbrite.ca
June 3, 2020
CV Risk Reduction in Diabetes (SGLT2i/GLP-1 RA and CVD)
Speaker: Dr. Richard Choi
Moderator: Dr. Sheldon Tobe
Learn more and register:
cvd-t2d-june3.eventbrite.ca
June 4, 2020
Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease
Speaker: Dr. Jeff Habert
Moderator: Dr. Sheldon Tobe
Learn more and register:
https://cvd-t2d-june4.eventbrite.ca
June 18, 2020
Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease
Speaker: Dr. Benedict Glover
Moderator: Dr. Sheldon Tobe
Learn more and register:
https://cvd-t2d-june18.eventbrite.ca
PLEASE NOTE: Workshops are limited to maximum 20 people each.
